San Diego 8910 University Center Lane Suite 400 San Diego, CA 92122 United States. Denali Therapeutics. Cygnal Therapeutics is the first company to develop drugs in the field of exoneural biology.
{cd}
Voyager is committed to...Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. In addition, our research efforts are focused on ways of combatting resistance mechanisms to existing drugs; We’re currently focused on diseases of the eye that cause significant vision loss such as wet age-related macular degeneration, geographic atrophy, diabetic macular edema and glaucoma.Neuraly, a biotech company founded on technology created at the Johns Hopkins School of Medicine, is focused on the development of neuroprotective agents for neurologic disorders such as Alzheimer's disease and Parkinson's disease.
Founded by scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference and neuroscience, Voyager Therapeutics was launched in 2014 with funding from leading life sciences investor Third Rock Ventures and is headquartered in Cambridge, Mass.Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Portland 4640 SW Macadam Ave Suite 200B Portland, OR 97239 United States. The company's pipeline is focused on CNS diseases in dire need of effective new therapies, including Parkinson's disease, a monogenic form of amyotrophic lateral sclerosis (ALS), Friedreich's ataxia and Huntington's disease. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis: Genentech has long been a leader in understanding and advancing the fields of cancer biology, cancer immunology and oncology drug discovery; We're constantly growing our expertise in Immunology so that we can continue to discover and develop innovative medicines for patients living with debilitating diseases, such as systemic lupus erythematosus, rheumatoid arthritis, asthma, inflammatory bowel disease, and idiopathic pulmonary fibrosis; Neurological and psychiatric disorders cause immense suffering and societal strain across the globe and their treatment remains a severe unmet need.
Marc Tessier-Lavigne, Ryan Watts, Alex Schuth and investors who share the vision that recent scientific insights in genetics, biology and translational medicine offer an unprecedented opportunity to discover and develop effective medicines for neurodegenerative disease. Description Source: VentureRadar Research / Company Website Denali Therapeutics Inc. Common Stock (DNLI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Trusted by Google, Microsoft, and most of the Fortune 500 to provide accurate contact information to their Sales and Business Development teams.